Gastroenterology
|
The Bridge of Experience: Applying Lessons Learned from HCV to the HBV-Infected Patient |
The Bridge of Experience: Applying Lessons Learned from HCV to the HBV-Infected Patient | |
| Don't miss out on the latest information in hepatitis B! Download your free CME/CE monograph today! |
|
| This comprehensive CME/CE monograph will focus on the key differences in the natural history and clinical management of hepatitis B virus (HBV) infection and hepatitis C virus (HCV) infection. It will also provide new clinical insights and proven treatment strategies (including information presented during The Liver Meeting 2004) for optimizing the management of patients with HBV infection. | |
| top |
|
TARGET AUDIENCE |
|
| This CME/CE activity is designed for gastroenterologists, hepatologists, and other clinicians who treat patients with viral hepatitis. | |
ACTIVITY GOAL |
|
| The goal of this CME/CE activity is to provide gastroenterologists, hepatologists, and other clinicians with new clinical insights and proven treatment strategies for optimizing the management of patients with hepatitis B virus (HBV) infection. | |
LEARNING OBJECTIVES |
|
|
|
| top | |
CME INFORMATION |
|
Statement of Accreditation |
|
| Projects In Knowledge is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. | |
Credit Designation |
|
| Projects In Knowledge designates this educational activity for a maximum of 2.5 Category 1 credits toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity. This activity is planned and implemented as an independent CME activity in accordance with the ACCME Essential Areas and Policies. |
|
Physician Assistants |
|
| Projects In Knowledge will issue a certificate of participation for the completion of this monograph. Please check with your organization and/or society for reciprocity. We will be counting credits earned for this monograph toward your certificate. | |
CE Information |
|
| This activity has been approved by the American Association of Critical-Care Nurses (AACN) for 3 contact hours. Provider #00012705. | |
|
|
| top | |
DISCLOSURE INFORMATION |
|
| The Disclosure Policy of Projects In Knowledge requires that presenters comply with the Standards for Commercial Support. All faculty are required to disclose any personal interest or relationship they or their spouse/partner have with the supporters of this activity or any commercial interest that is discussed in their presentation. Any discussions of unlabeled/unapproved uses of drugs or devices will also be disclosed in the course materials. | |
For complete prescribing information on the products discussed during this CME/CE activity, please see your current Physicians' Desk Reference (PDR). |
|
Mario Pessoa, MD, PhD, has received grant/research support from Bristol-Myers Squibb Company and Roche Pharmaceuticals; is a consultant for Bristol-Myers Squibb Company; and is on the speakers bureau of Roche Pharmaceuticals and GlaxoSmithKline. |
|
Eugene R. Schiff, MD, has received grant/research support from Bayer Corporation, Bristol-Myers Squibb Company, GlaxoSmithKline, Ortho Biotech Products, LP, Ortho Diagnostics, Roche Diagnostics, Schering-Plough Corporation, and SciClone Pharmaceuticals International Ltd; is a consultant for Achillion Pharmaceuticals, Inc, Gilead Sciences, Inc, GlaxoSmithKline, Idenix Pharmaceuticals Inc, Novartis Pharmaceuticals Corporation, and Schering-Plough Corporation; and is on the speakers bureau of AstraZeneca LP, Bayer Corporation, Gilead Sciences, Inc, GlaxoSmithKline, Ortho Biotech Products, LP, Ortho Diagnostics, and Schering-Plough Corporation. |
|
Norah A. Terrault, MD, MPH, has received grant/research support from Cangene Corporation, Gilead Sciences, Inc, Idun Pharmaceuticals, InterMune, Inc, Roche Pharmaceuticals, and XTL Pharmaceuticals; is a consultant for Bayer Corporation and Bristol-Myers Squibb Company; and is on the speakers bureau of Schering-Plough Corporation. |
|
Tram T. Tran, MD, has received grant/research support from and is on the speakers bureau of Gilead Sciences, Inc, Roche Pharmaceuticals, and Schering-Plough Corporation. |
|
Peer Reviewer has disclosed no significant relationships. |
|
Projects In Knowledge's staff members have no significant relationships to disclose. |
|
Conflicts of interest are thoroughly vetted by the Executive Committee of Projects In Knowledge. All conflicts are resolved prior to the beginning of the activity by the Trust In Knowledge peer review process. |
|
The opinions expressed in this activity are those of the faculty and do not necessarily reflect those of Projects In Knowledge. |
|
This CME/CE activity is provided by Projects In Knowledge solely as an educational service. Specific patient care decisions are the responsibility of the clinician caring for the patient. |
|
This independent CME/CE activity is supported by an educational grant from Bristol-Myers Squibb Company. | |
| top
1699 |
|
|
|



